Zobrazeno 1 - 10
of 18
pro vyhledávání: '"J R, Bravo González"'
Publikováno v:
Revista cubana de medicina tropical. 51(1)
Dengue is at present the most important human arbovirosis. It is the main cause of hospitalization and death among children from southeast Asia. Two fifth of the world population live in dengue risk areas. In 1997, over 100 countries reported epidemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9d098488592066c03ab9ea04684480f8
https://pubmed.ncbi.nlm.nih.gov/10887549
https://pubmed.ncbi.nlm.nih.gov/10887549
Autor:
M, Díaz González, O, Navia Molina, A, Urbino López-Chávez, L, Rodríguez Lay, J R, Bravo González, P, Pedroso Flaquet
Publikováno v:
Revista cubana de medicina tropical. 51(1)
The Heberbiovac-HB recombinant hepatitis B vaccine was administered at dosages of 10.5 and 2.5 micrograms in 3 groups of children aged 6-9 with a vaccination schedule at 0, 1 and 6 months of age. The immunogenecity attained between dosages was compar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e109d6f5dda6d130b58249fc79ecf22d
https://pubmed.ncbi.nlm.nih.gov/10887555
https://pubmed.ncbi.nlm.nih.gov/10887555
Autor:
M, Suárez Hernández, M, Alonso Castellano, R, Peláez Martínez, B, Sánchez Pérez, J R, Bravo González, A, Sánchez Sibello
Publikováno v:
Revista cubana de medicina tropical. 49(2)
A descriptive study of cases was conducted in which 781 sera were investigated using the indirect immunofluorescent technique with antigens of Babesia bovis and Babesia bigemina at the National Center for Agricultural Health. Of them, 371 came from a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b107925691e32f134d54c1fdaf4fd17f
https://pubmed.ncbi.nlm.nih.gov/9685976
https://pubmed.ncbi.nlm.nih.gov/9685976
Publikováno v:
Revista cubana de medicina tropical. 49(1)
The recombinant DNA Heberbiovac-HB vaccine against hepatitis B was applied to 2 groups of children at 2 homes for the physically and mental disabled at doses of 10 and 5 micrograms with the scheme 0, 1 and 6 months to study its immunogenicity, which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a6f5ae5b6392de093fbe782404e41fea
https://pubmed.ncbi.nlm.nih.gov/9685963
https://pubmed.ncbi.nlm.nih.gov/9685963
Autor:
M, Díaz González, L, Rodríguez Lay, A U, López-Chávez, J R, Bravo González, P, Pedroso Flaquet
Publikováno v:
Revista cubana de medicina tropical. 49(3)
The Cuban recombinant yeast-derived hepatitis B vaccine (Heberbiovac-HB) was administered to 2 groups of infants aged 3 months. A dosage of 10 micrograms was used through a scheme of 0, 1 and 6 and 0, 1, 2 and 12, coinciding with the DPT and anti-men
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::366246d904b68576f1856fc31dfc9d03
https://pubmed.ncbi.nlm.nih.gov/9685987
https://pubmed.ncbi.nlm.nih.gov/9685987
Autor:
E, González Ochoa, L, Armas Pérez, J R, Bravo González, J, Cabrales Escobar, R, Rosales Corrales, G, Abreu Suárez
Publikováno v:
Bulletin of the Pan American Health Organization. 30(2)
Acute respiratory infections (ARI), the leading class of ailments causing people to seek health care, rarely require antibiotics. Nevertheless, many physicians prescribe them needlessly. Hence, reducing the unnecessary use of antibiotics is one aim o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f631ce81e1325251de7aa43c161a8026
https://pubmed.ncbi.nlm.nih.gov/8704751
https://pubmed.ncbi.nlm.nih.gov/8704751
Autor:
M, Díaz González, A, Chiang Macía, D, Díaz Acosta, J R, Bravo González, L, Rodríguez Lay, P, Pedroso Flaquet, A U, López-Chávez
Publikováno v:
Revista cubana de medicina tropical. 48(3)
The Cuban recombinant vaccine against hepatitis B virus was applied with doses of 10 ìg to children under 15 in a scheme from 0, 1 to 6 months. The immunogenicity was evaluated at 2, 7, and 12 months and showed 100% of seroconversion with protective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::124623f152beb659e09d1ad72d1eb842
https://pubmed.ncbi.nlm.nih.gov/9805051
https://pubmed.ncbi.nlm.nih.gov/9805051
Publikováno v:
Revista cubana de medicina tropical. 47(1)
Reactogenicity was measured after applying the Heberbiovac-HB recombinant vaccine against hepatitis B virus to three groups of children aged 6-9 years. The vaccine was derived from yeast cells, administered at doses of 10, 5, and 2.5 g, with a schedu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::95e9d7d32bdefd5890ab7c7881f0988d
https://pubmed.ncbi.nlm.nih.gov/9805071
https://pubmed.ncbi.nlm.nih.gov/9805071
Publikováno v:
Revista cubana de medicina tropical. 46(2)
The effectiveness or post-license efficacy of the BC antimeningococcal vaccine (VA-MENGOC-BC) was assessed 1 year after the end of the immunization campaign in children aged 0 to 5 years. Occurrence of the disease before and after intervention is des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cf79cec8ce90ae865bbc01ffe658c19d
https://pubmed.ncbi.nlm.nih.gov/9768243
https://pubmed.ncbi.nlm.nih.gov/9768243
Autor:
R, Machín Sánchez, R, Martínez Sánchez, A, Fachado Carbajales, J, Pividal Grana, J R, Bravo González
Publikováno v:
Revista cubana de medicina tropical. 45(2)
A national seroepidemiological survey was carried out to assess the prevalence of anti-Toxoplasma gondii antibodies. 8863 samples taken in filter paper through the ELISA test were analyzed and 29.70% positivity was obtained. No significant difference
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3151d063573d0f3f04c72048d6225302
https://pubmed.ncbi.nlm.nih.gov/7984820
https://pubmed.ncbi.nlm.nih.gov/7984820